Suppr超能文献

变应原免疫疗法的最新进展。

Update on Allergen Immunotherapy.

作者信息

Mueller Ralf S

机构信息

Centre for Clinical Veterinary Medicine, Medizinische Kleintierklinik, LMU Munich, Veterinaerstr. 13, Munich 80539, Bavaria, Germany.

出版信息

Vet Clin North Am Small Anim Pract. 2019 Jan;49(1):1-7. doi: 10.1016/j.cvsm.2018.08.001. Epub 2018 Sep 15.

Abstract

Allergen immunotherapy has been used for many years in dogs and cats and is the only specific treatment of atopic dermatitis that changes the patho-mechanisms of disease by stimulating allergen tolerance. Subcutaneous administration of allergens is the most commonly used administration route, typically in increasing concentrations (induction period) followed by long-term injection of allergen extract (maintenance therapy). Rush protocols with an abbreviated induction period have been reported and shown to be safe in dogs. More recently, oro-mucosal and intralymphatic administration of allergens has been evaluated in dogs. Approximately two-thirds of patients show good to excellent improvement of clinical signs.

摘要

变应原免疫疗法已在犬猫中应用多年,是唯一一种通过刺激变应原耐受性来改变疾病病理机制的特应性皮炎特异性治疗方法。变应原皮下给药是最常用的给药途径,通常先给予递增浓度的变应原(诱导期),随后长期注射变应原提取物(维持治疗)。已有报道称犬的快速免疫方案诱导期缩短且已证明是安全的。最近,已对犬的变应原口腔黏膜给药和淋巴管内给药进行了评估。约三分之二的患者临床症状有良好至极佳的改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验